Invention Grant
US08735548B2 Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof
有权
结合SCNN1A / TNFRSF1A融合蛋白的抗体及其使用方法
- Patent Title: Antibodies which bind to SCNN1A/TNFRSF1A fusion proteins and methods of use thereof
- Patent Title (中): 结合SCNN1A / TNFRSF1A融合蛋白的抗体及其使用方法
-
Application No.: US13805321Application Date: 2011-06-28
-
Publication No.: US08735548B2Publication Date: 2014-05-27
- Inventor: Kim Coign Quon , Gene Cutler , Jennifer Joy Kordich
- Applicant: Kim Coign Quon , Gene Cutler , Jennifer Joy Kordich
- Applicant Address: US CA Thousand Oaks
- Assignee: Amgen Inc.
- Current Assignee: Amgen Inc.
- Current Assignee Address: US CA Thousand Oaks
- Agent Julie K. Smith
- International Application: PCT/US2011/042201 WO 20110628
- International Announcement: WO2012/012141 WO 20120126
- Main IPC: C12P21/08
- IPC: C12P21/08 ; C07K16/00 ; G01N33/574
Abstract:
The present invention provides fusion proteins expressed by cancer cells, antibodies and other antigen-binding agents that specifically bind to the fusion proteins, and compositions and methods for using the antibodies and other antigen-binding agents to detect, characterize, and treat cancer.
Public/Granted literature
- US20130095111A1 FUSION PROTEINS IN CANCER Public/Granted day:2013-04-18
Information query
